首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1524258

瓣環成形術系統市場 - 按剛性、按應用、按形狀、按最終用途和預測，2024 年至 2032 年

Annuloplasty System Market - By Rigidity, By Application, By Shape, By End-use & Forecast, 2024 - 2032

出版日期: 2024年04月26日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於外科心臟瓣膜修復和置換手術的普及，全球瓣環成形系統市場預計從 2024 年到 2032 年複合年成長率將超過 8.2%。根據疾病管制與預防中心的數據，瓣膜性心臟病影響著 2.5% 的人口和 13% 的 80 歲及以上老年人。這增加了對瓣環成形系統的巨大需求，以治療這些疾病並改善患者的治療效果。

隨著醫療保健提供者優先考慮二尖瓣和三尖瓣疾病等心血管疾病的有效治療，對可靠的瓣環成形術解決方案的需求不斷成長。外科干預措施的激增凸顯了旨在改善患者治療效果和生活品質的先進醫療干預措施的更廣泛趨勢。隨著全球越來越多的患者選擇手術治療，在有效解決和管理心臟健康的迫切需求的推動下，市場不斷擴大。

整個瓣環成形系統市場根據剛性、應用、形狀、最終用途和區域進行分類。

由於手術技術和材料的進步，從 2024 年到 2032 年，軟性細分市場的複合年成長率將大幅成長。這些系統在滿足心臟瓣膜修復手術期間不同的解剖複雜性和患者特定需求方面提供了更大的靈活性和適應性。軟性瓣環成形環和帶的創新使外科醫生能夠實現更精確的調整和更好的結果，從而最大限度地降低術後併發症的風險。這種靈活性趨勢反映了向個人化醫療和微創方法的更廣泛轉變，刺激了有效適應不同患者狀況的瓣環成形系統的採用。

到 2032 年，由於人們越來越認知到三尖瓣疾病及其對心臟健康的影響，三尖瓣修復領域將在瓣環成形術系統市場中佔據顯著佔有率。隨著意識和診斷能力的提高，越來越多的患者被診斷出三尖瓣關閉不全，促使人們更加需要瓣環成形術等有效的治療方案。這些系統在恢復瓣膜功能和改善患者預後方面發揮著至關重要的作用，特別是在需要手術干預的情況下。針對三尖瓣修復的瓣環成形技術的進步正在提高手術精度和術後恢復，從而擴大了其在臨床實踐中的應用。

2024年至2032年，亞太地區瓣環成形系統市場將呈現強勁的複合年成長率。心臟治療的需求。此外，亞太地區人口老化導致心臟瓣膜疾病的發生率升高，因此需要進行包括瓣環成形術在內的外科手術介入。醫療保健設施的改善和微創手術技術的採用鼓勵了亞太地區的市場擴張。這些因素共同凸顯了增強心臟護理能力的日益成長的趨勢。

產業生態系統分析
產業影響力
- 成長動力
  - 心血管疾病負擔日益加重
  - 瓣環成形術系統的技術進步
  - 對微創手術的需求不斷成長
- 產業陷阱與挑戰
  - 潛在的併發症和不良事件
成長潛力分析
監管環境
技術景觀
未來市場趨勢
報銷場景
波特的分析
PESTEL分析
缺口分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按剛性分類，2021 - 2032 年

主要趨勢
靈活的
死板的
半剛性

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
二尖瓣修復
三尖瓣修復
主動脈瓣修補

第 7 章：市場估計與預測：按形狀分類，2021 - 2032

主要趨勢
打開
關閉

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
心導管實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
Affluent Medical
BioStable Science & Engineering
Corcym UK Limited
Coroneo
Edwards Lifesciences Corporation
Genesee BioMedical
Medtentia International Ltd Oy
Medtronic plc
Micro Interventional Devices Incorporated

簡介目錄

Product Code: 9243

Global Annuloplasty System Market will imply over 8.2% CAGR from 2024 to 2032, driven by the prevalence of surgical heart valve repair and replacement procedures. As per the Centers for Disease Control and Prevention, valvular heart disease influences 2.5% of the population and 13% of those aged 80 years and above. This has strengthened significant demand for annuloplasty systems to treat these conditions and enhance patient outcomes.

As healthcare providers prioritize effective treatments for cardiovascular conditions such as mitral and tricuspid valve disorders, the need for reliable annuloplasty solutions has grown. This surge in surgical interventions underscores a broader trend towards advanced medical interventions aimed at improving patient outcomes and quality of life. With a rising number of patients opting for surgical treatments globally, the market continues to expand, driven by the imperative to address and manage cardiac health effectively.

The overall annuloplasty system market is categorized based on rigidity, application, shape, end-use, and region.

The flexible segment will experience considerable CAGR expansion from 2024 through 2032, owing to surgical techniques and materials advancements. These systems offer greater flexibility and adaptability in addressing varying anatomical complexities and patient-specific needs during heart valve repair procedures. Innovations in flexible annuloplasty rings and bands allow surgeons to achieve more precise adjustments and better outcomes, minimizing the risk of postoperative complications. This trend towards flexibility reflects a broader shift towards personalized medicine and minimally invasive approaches, spurring the adoption of annuloplasty systems that accommodate diverse patient conditions effectively.

By 2032, the tricuspid valve repair segment will achieve a prominent annuloplasty system market share because of a growing recognition of tricuspid valve disorders and their impact on cardiac health. As awareness and diagnostic capabilities improve, more patients are diagnosed with tricuspid valve regurgitation, prompting a greater need for effective treatment options like annuloplasty. These systems play a crucial role in restoring valve function and improving patient outcomes, especially in cases where surgical intervention is necessary. Advances in annuloplasty technologies tailored for tricuspid valve repair are enhancing surgical precision and postoperative recovery, escalating their adoption in clinical practice.

The Asia Pacific annuloplasty system market will exhibit a robust CAGR from 2024 to 2032. Rising healthcare expenditures and increasing awareness and diagnosis of cardiovascular diseases are thrusting demand for advanced cardiac treatments, including annuloplasty procedures. Additionally, the Asia Pacific's aging population is contributing to higher incidences of heart valve disorders, necessitating surgical interventions that include annuloplasty. Improved access to healthcare facilities and the adoption of minimally invasive surgical techniques encourages market expansion in the Asia Pacific. These factors collectively underscore a growing trend toward enhancing cardiac care capabilities.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing burden of cardiovascular diseases
  - 3.2.1.2 Technological advancements in annuloplasty systems
  - 3.2.1.3 Rising demand for minimally invasive procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Potential complications and adverse events
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Reimbursement scenario
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Rigidity, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Flexible
5.3 Rigid
5.4 Semi-rigid

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Mitral valve repair
6.3 Tricuspid valve repair
6.4 Aortic valve repair

Chapter 7 Market Estimates and Forecast, By Shape, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Open
7.3 Closed

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Cardiac catheterization labs
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa